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Synopsis 
 
Significant advancements in genome sequencing techniques and other high-throughput 
initiatives have resulted in the availability of complete sequences of genomes of a large number 
of organisms, which provide an opportunity to study detailed biological information encoded 
therein. Identification of functional roles of proteins can aid in comprehension of various 
cellular activities in an organism, which is traditionally achieved using techniques pertaining to 
the field of molecular biology, protein chemistry and macromolecular crystallography. The 
established experimental methods for protein structure and function determination, although 
accurate and resourceful, are laborious and time consuming. Computational analyses of 
sequences of gene products and exploration of evolutionary relationships can give clues on 
protein structure and/or function with reasonable accuracy which can be used to direct 
experimental studies on proteins of interest, effectively. Moreover, with growing volumes of 
data, there has been a growing disparity in the number of well-characterized and 
uncharacterized proteins, further necessitating the use of computational methods for 
investigating evolutionary and structure-function relationships.  
The remarkable progress made in the development of computational techniques (Chapter 1) 
has immensely contributed to the state-of-the-art biological sequence analysis and recognition 
of protein structure and function in a reliable manner. These methods have largely influenced 
the exploration of protein sequence-structure-function space.  
One of the relevant applications of computational approaches is in the understanding of 
functional make-up of human pathogens, their complex interplay with the host and 
implications in pathogenesis. In this thesis, sensitive profile-based search procedures have been 
utilized to address various aspects in the context of three pathogens- Mycobacterium 
tuberculosis, Plasmodium falciparum and Trypanosoma brucei, which are causative agents of 
potentially life-threatening diseases. The existing drugs approved for the diseases, although of 
immense value in controlling the disease, have several shortcomings, the most important of 
them being the emergence of drug resistance that render the current treatment regimens futile. 
Thus, the identification of practicable targets and new drugs or new combination therapies 
become an important necessity. Analyses on structural and functional repertoire of proteins 
encoded in the pathogenic genomes can provide means for rational identification of therapeutic 
intervention strategies. 
This thesis begins with the computational analyses of proteins encoded in M. tuberculosis 
genome. M. tuberculosis is a primary aetiological agent of tuberculosis in humans, and is 
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responsible for an estimated 1.5 million deaths every year. The complete genome of the 
pathogen was sequenced and made available more than a decade ago, which has been valuable 
in determination of functional roles of its gene products. Yet, functions of many M. tuberculosis 
proteins remain unknown. Computational prediction of protein function is an on-going 
process based on ever growing information made available in public databases as well as the 
introduction of powerful homology recognition techniques. Hence, a continuous refinement is 
essential to make the most of the sequence data, ensuring its accuracy and relevance. With the 
use of multiple sequence and structural profile-based search procedures, an enhanced structural 
and functional characterization of M. tuberculosis proteins, totalling to 95% of the genome was 
achieved (Chapter 2). Following are the key findings.  
o Domain definitions were obtained for a total of 3566 of 4018 proteins. Amino acid 
residue coverage of >70% was achieved for 2295 proteins which constitute more than 
half of the proteome. 
o Domain assignments were newly identified for 244 proteins with domain-unassigned 
regions. Structure prediction for these proteins corroborated all the remote homology 
relationships recognized using profile-based methods, enhancing the reliability of the 
predictions.  
o Comparison on domain compositions of proteins between M. tuberculosis and human 
host, revealed presence of pathogen-specific domains that are not homologous to 
proteins in human. Such proteins in M. tuberculosis are mainly virulence factors 
involved in host-pathogen interactions such as immune-dominance and aiding entry 
and survival in human host macrophages, hence forming attractive targets for drug 
discovery. 
o Putative structural and functional information for proteins with no recognizable 
domains were inferred by means of fold recognition and an iterative profile-based 
search against sequence database.   
o Attributing putative structures and functions to 955 conserved hypothetical proteins in 
M. tuberculosis, 137 of which are reportedly essential to the pathogen, provide a basis to 
re-investigate their involvement in pathogenesis and survival in the host.  
o Proteins with no detectable homologues were recognized as M. tuberculosis H37Rv-
specific, which can serve as promising drug targets. 
o An attempt was made to identify porin-like proteins in M. tuberculosis, considering 
MspA porin from M. smegmatis as a template. The difficulty in recognition of putative 
porins in M. tuberculosis is indicative of novel outer membrane channel proteins, not 
characterized yet, or high representation of ion-channels, symporters and transporters 
to compensate for the functional role of porins. In addition, MspA-like proteins were 
not readily recognized in other slow-growing mycobacterial pathogens that are known 
to infect human host, apart from M. tuberculosis. This indicates probable acquisition of 
physiological adaptations, i.e. absence of porins, to confer drug-resistance, in the course 
of their co-evolution with human hosts. 
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o Evolutionary relationships recognized between sequence (Pfam) and structural (SCOP) 
families aided in association of potential structures and/or functions for 55 
uncharacterized Pfam domains recognized in M. tuberculosis. Such associations deliver 
useful insights into the structure and function of a protein housing the uncharacterized 
domain.  
The functional inferences drawn for M. tuberculosis proteins based on the predictions can 
provide valuable basis for experimental endeavours in understanding mechanisms of 
pathogenesis and can significantly impact anti-tubercular drug discovery programmes.  
An interesting outcome benefitted from the exercise of exploring relationships between Pfam 
and SCOP families, was the identification of evolutionary relationship between a Pfam domain 
of unknown function DUF2652 and class III nucleotidyl cyclases. A detailed investigation was 
undertaken to assess this relationship (Chapter 3). Nucleotidyl cyclases synthesize cyclic 
nucleotides which are critical second messengers in signalling pathways. The DUF2652 family 
predominantly comprises of bacterial proteins belonging to three lineages- Actinobacteria, 
Bacteroidetes and Proteobacteria. Thus, recognition of evolutionary relationship between these 
bacterial proteins and nucleotide cyclases is of particular interest due to the indispensability of 
cyclic nucleotides in regulation of varied biological activities in bacteria. Use of fold recognition 
program suggested presence of nucleotide cyclase-characteristic topological motif (βααββαβ) 
in all the members of the DUF2652 family. Detailed analyses on structural and functional 
features of the uncharacterized set of bacterial proteins corresponding to 50 bacterial genomes, 
using profile-based alignments, revealed presence of key features typical of nucleotidyl cyclases, 
including metal-binding aspartates, substrate-specifying residues and transition-state 
stabilizing residues. Depending on the features, 20 proteins of Actinobacteria lineage, 
predominantly mycobacteria, of unknown structure and function were identified as putative 
nucleotide cyclases, 23 proteins of Bacteroidetes lineage were associated with guanylyl cyclases, 
while 8 uncharacterized proteins of Proteobacteria were recognized as nucleotide cyclase-like 
proteins (7 adenylyl and one guanylyl cyclase). Sequence similarity-based clustering of the 
predicted nucleotide cyclase-like proteins with established nucleotide cyclases indicated the 
apparent evolutionarily distinctness of the subfamily of class III nucleotidyl cyclases predicted. 
Furthermore, analysis of evolutionarily conserved gene clusters of the predicted nucleotide 
cyclase-like proteins indicated functional associations that support the predictions on their 
participation in cellular signalling events. The inferences made can be experimentally 
investigated further to ascertain the involvement of the uncharacterized bacterial proteins in 
signalling pathways, which can help in understanding the pathobiology of pathogenic species 
of interest.  
The next objective was the recognition of biologically relevant protein-protein interactions 
across M. tuberculosis and human host (Chapter 4). M. tuberculosis is well known for its ability 
to successfully co-evolve with human host in terms of establishing infection, survival and 
persistence. The current knowledge on the mechanisms of host invasion, immune evasion and 
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persistence in the host environment can be attributed, and is limited, to the experimental studies 
pursued by numerous groups. Chapter 4 presents an approach for computational identification 
of biologically feasible protein-protein interactions across M. tuberculosis and human host. The 
approach utilizes crystal structures of intra-organism protein-protein complexes which are 
transient in nature. Identification of homologues of host and pathogen proteins in the database 
of known protein-protein interactions, formed the initial step, followed by identification of 
conserved interfacial patch and integration of information on tissue-specific expression of 
human proteins and subcellular localization of human and M. tuberculosis proteins. In addition, 
appropriate filters were used to extract biologically feasible host-pathogen protein-protein 
interactions. This resulted in recognition of 386 interactions potentially mediated by 59 M. 
tuberculosis proteins and 90 human proteins. A predominance of host-pathogen interactions 
(193 protein-protein interactions) brought about by M. tuberculosis proteins participating in 
cell wall processes, was observed, which is in concurrence with the experimental studies on 
immuno-modulatory activities brought about by such proteins. These set of mycobacterial 
proteins were predicted to interact with diverse set of host proteins such as those involved in 
ubiquitin conjugation pathways, metabolic pathways, signalling pathways, regulation of cell 
proliferation, transport, apoptosis and autophagy. The predictions have the potential to 
complement experimental observations at the molecular level. Details on couple of interesting 
cases are presented in the chapter, one of which is the probable mechanism of immune evasion 
adopted by M. tuberculosis to inhibit lysozyme activity in macrophages, and second is the 
mechanism of nutrient uptake from host. The set of M. tuberculosis proteins predicted to 
mediate interactions with host proteins have the potential to warrant an experimental follow-
up on probable mechanisms of pathogenesis and also serve as attractive targets for 
chemotherapeutic interventions. 
One of the major shortcomings with current treatment regimen for tuberculosis is the 
emergence of multidrug (MDR) and extensively drug-resistant (XDR) strains that render first-
line and second-line drug treatments futile. This entails a need to explore target space in M. 
tuberculosis as well as explore the potential of existing drugs for repurposing against 
tuberculosis. A drug repurposing strategy i.e. exploring within-target-family selectivity of small 
molecules, has been implemented (Chapter 5) to contribute towards time and cost-saving anti-
tubercular drug development efforts. With the use of profile-based search procedures, 
evolutionary relationships between targets (other than proteins of M. tuberculosis) of FDA-
approved drugs and M. tuberculosis proteins were investigated. A key filter to exclude drugs 
capable of acting on human proteins substantially reduced the chances of obtaining anti-targets. 
Thus, total of 130 FDA-approved drugs were recognized that can be repurposed against 78 M. 
tuberculosis proteins, belonging to the functional categories- intermediary metabolism and 
respiration, information pathways, cell wall and cell processes and lipid metabolism. The 
catalogue of structure and function of M. tuberculosis proteins and their involvement in host-
pathogen protein-protein interactions compiled from chapters 2 and 4 served as a guiding tool 
to explore the functional importance of targets identified. Many of the potential targets 
identified have been experimentally shown to be essential for growth and survival of the 
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pathogen earlier, thus gaining importance in terms of pharmaceutical relevance. 
Polypharmacological drugs or drugs capable of acting of multiple targets were also identified 
(92 drugs) in the study. These drugs have the potential to stand tolerance against development 
of drug resistance in the pathogen. Comparative sequence and structure-based analysis of M. 
tuberculosis proteins homologous to known targets yielded credible inferences on putative 
binding sites of FDA-approved drugs in potential targets. Instances where information on 
binding sites could not be readily inferred from known targets, potentially druggable sites have 
been predicted. Comparison with earlier experimental studies that report anti-tubercular 
potential of several approved drugs enhanced the credibility of 74 of 130 FDA-approved drugs 
that can be readily prioritized for clinical studies. An additional exercise was pursued to identify 
prospective anti-tubercular agents by means of structural comparison between ChEMBL 
compounds and 130 FDA-approved drugs. Only those compounds were retained that showed 
considerably high structural similarity with approved drugs. Such compounds with minor 
changes in terms of physicochemical properties provide a basis for exploration of compounds 
that may exhibit higher affinities to bind to M. tuberculosis targets. The set of approved drugs 
recognized as repurpose-able candidates against tuberculosis, in concert with the structurally 
similar compounds, can significantly impact anti-tubercular drug development and drug 
discovery.  
The next part of the thesis focuses on Plasmodium falciparum, an obligate intracellular 
protozoan parasite responsible for malaria. The parasite genome features unusual 
characteristics including abundance of low complexity regions and pronounced sequence 
divergence that render protein structure and function recognition difficult. The parasite also 
manifests remarkable plasticity in its metabolic organization throughout its developmental 
stages in two hosts-human and mosquito; thus obtaining an exhaustive list of metabolic 
proteins in the parasite gains importance. Considering the utility of multiple sensitive profile-
based search approaches in enhanced annotation of M. tuberculosis genome, a similar exercise 
was employed to recognize potential metabolic proteins in P. falciparum (Chapter 6). A total of 
172 metabolic proteins were identified as participants of 78 metabolic pathways, over and above 
609 proteins known to participate in P. falciparum metabolism. Pathway holes, where evidence 
on metabolic step exists but the catalysing enzyme is not known, have also been addressed in 
the study, several of which have been suggested to play an important role in growth and 
development of the parasite during its intra-erythrocytic stages in human host.  
A subsequent objective was the recognition P. falciparum proteins potentially capable of 
remodelling erythrocytes to suit their niche (Chapter 7). Exploitative mechanisms are brought 
about by the parasite to remodel erythrocytes for growth and survival during intra-erythrocytic 
stages of its life-cycle, the understanding of which is limited to experimental studies.  To achieve 
physicochemically viable protein-protein interactions potentially mediated by proteins of 
human erythrocytes and P. falciparum proteins, a structure-influenced protocol, similar to the 
one demonstrated in Chapter 4, was employed. Information on subcellular localization and 
protein expression is crucial especially for parasites like P. falciparum, which reside in 
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heterogeneous environmental conditions at different stages in their lifecycle. Inclusion of such 
data aided in extraction of 208 biologically relevant protein-protein interactions potentially 
mediated by 59 P. falciparum proteins and 30 erythrocyte proteins. Host-parasite protein-
protein interactions were predicted pertaining to several major strategies spanning intra-
erythrocytic stages in P. falciparum pathogenesis including- gaining entry into the host 
erythrocytes (category: RBC invasion, protease), redirecting parasitic proteins to erythrocyte 
membrane (category: protein traffic), modulating erythrocyte machinery (category: rosette 
formation, putative adhesin, chaperone, kinase), evading immunity (category: immune 
evasion) and eventually egress (category: merozoite egress) to infect other uninfected 
erythrocytes. Elaborate means to analyse and evaluate the functional viability of a predicted 
interaction in terms of geometrical packing at the interfacial region, electrostatic 
complementarity of the interacting surfaces and interaction energies is also demonstrated. The 
protein-protein interactions, thus predicted between human erythrocytes and P. falciparum, 
have the potential to provide a useful basis in understanding probable mechanisms of 
pathogenesis, and indeed in pinning down attractive targets for antimalarial drug discovery.   
The emergence of drug resistance against all known antimalarial agents, currently in use, 
necessitates discovery and development of either new antimalarial agents or unexplored 
combination of drugs that may not only reduce mortality and morbidity of malaria, but also 
reduce the risk of resistance to antimalarial drugs. In an attempt to contribute towards the same, 
Chapter 8 explores the established concept of within-target-family selectivity of small molecules 
to recognize antimalarial potential of the approved drugs. Eighty six FDA-approved drugs, 
predominantly constituted by antibacterial agents, were identified as feasible candidates for 
repurposing against 90 P. falciparum proteins. Most of the potential parasite targets identified 
are known to participate in housekeeping machinery, protein biosynthesis, metabolic pathways 
and cell growth and differentiation, and thus are pharmaceutically relevant. During intra-
erythrocytic growth of P. falciparum, the parasite resides within the erythrocyte, within a 
protective encasing, known as parasitophorous vacuole. Hence a drug, intended to target a 
parasite protein residing in an organelle, must be sufficiently hydrophilic or hydrophobic to be 
able to permeate cell membranes and reach its site of activity. On the basis of lipophilicity of the 
drugs, a physical property determined experimentally, 57 of 86 FDA-approved drugs were 
recognized as feasible candidates for use against P. falciparum during the course of blood-stages 
of infection, which can be prioritized for antimalarial drug development programmes.  
The final section of the thesis focuses on the protozoan parasite Trypanosoma brucei, a causative 
agent of African sleeping sickness (Chapter 9). This disease is endemic to sub-Saharan regions 
of Africa. Despite the availability of completely sequenced genome of T. brucei, structure and 
function for about 50% of the proteins encoded in the genome remain unknown. Absence of 
prophylactic chemotherapy and vaccine, compounded with emergence of drug-resistance 
renders anti-trypanosomal drug discovery challenging. Thus, considering the utility of 
frameworks established in earlier chapters for recognition of protein structure, function and 
drug-targets, similar steps were undertaken to understand functional repertoire of the parasite 
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and use drug repurposing methods to accelerate anti-trypanosomal drug discovery efforts. 
Structures and functions were reliably recognized for 70% of the gene products (5894) encoded 
in T. brucei genome, with the use of multiple profile-based search procedures, coupled with 
information on presence of transmembrane domains and signal peptide cleavage sites. 
Consequently, a total of 282 uncharacterized T. brucei proteins could be newly coined as 
potential metabolic proteins. Integration of information on stage-specific expression profiles 
with Trypanosoma-specific and T-.brucei-specific proteins identified in the study, aided in 
pinning down potential attractive targets. Additionally, exploration of evolutionary 
relationships between targets of FDA-approved drugs and T. brucei proteins, 68 FDA-approved 
drugs were predicted as repurpose-able candidates against 42 potential T. brucei targets which 
primarily include proteins involved in regulatory processes and metabolism. Several targets 
predicted are reportedly essential in assisting the parasite to switch between differentiation 
forms (bloodstream and procyclic) in the course of its lifecycle. These targets are of high 
therapeutic relevance, hence the corresponding drug-target associations provide a useful 
resource for experimental endeavours. 
In summary, this thesis presents computational analyses on three pathogenic genomes in terms 
of enhancing the understanding of functional repertoire of the pathogens, addressing metabolic 
pathway holes, exploring probable mechanisms of pathogenesis brought about by potential 
host-pathogen protein-protein interactions, and identifying feasible FDA-approved drug 
candidates to repurpose against the pathogens. The studies are pursued primarily by taking 
advantage of powerful homology-detection techniques and the ever-growing biological 
information made available in public databases. Indeed, the inferences drawn for the three 
pathogenic genomes serve an excellent resource for an experimental follow-up. The set of 
protocols presented in the thesis are highly generic in nature, as demonstrated for three 
pathogens, and can be utilized for genome-wide analyses on many other pathogens of interest.  
The supplemental data associated with the chapters is provided in a compact disc attached with 
this thesis.  
